iRadimed Corporation (IRMD): Price and Financial Metrics

iRadimed Corporation (IRMD)

Today's Latest Price: $23.92 USD

0.15 (-0.62%)

Updated Nov 27 1:00pm

Add IRMD to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 143 in Medical - Devices & Equipment

See all "A" rated Strong Buy stocks

IRMD Stock Summary

  • IRMD's current price/earnings ratio is 73.87, which is higher than 88.15% of US stocks with positive earnings.
  • The price/operating cash flow metric for Iradimed Corp is higher than 89.66% of stocks in our set with a positive cash flow.
  • In terms of volatility of its share price, IRMD is more volatile than merely 4.72% of stocks we're observing.
  • Stocks that are quantitatively similar to IRMD, based on their financial statements, market capitalization, and price volatility, are TTGT, CNS, AAON, HMSY, and CBPO.
  • Visit IRMD's SEC page to see the company's official filings. To visit the company's web site, go to

IRMD Stock Price Chart Interactive Chart >

Price chart for IRMD

IRMD Price/Volume Stats

Current price $23.92 52-week high $28.43
Prev. close $24.07 52-week low $14.41
Day low $23.58 Volume 10,900
Day high $24.30 Avg. volume 45,403
50-day MA $22.29 Dividend yield N/A
200-day MA $22.11 Market Cap 293.50M

iRadimed Corporation (IRMD) Company Bio

IRadimed Corporation manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible products in the United States and internationally. The company was founded in 1992 and is based in Winter Springs, Florida.

IRMD Latest News Stream

Event/Time News Detail
Loading, please wait...

IRMD Latest Social Stream

Loading social stream, please wait...

View Full IRMD Social Stream

Latest IRMD News From Around the Web

Below are the latest news stories about Iradimed Corp that investors may wish to consider to help them evaluate IRMD as an investment opportunity.

IRadimed Corp (IRMD) CEO Roger Susi on Q2 2020 Results - Earnings Call Transcript

IRadimed Corp (IRMD) Q2 2020 Earnings Conference Call July 30, 2020 11:00 AM ET Company Participants Roger Susi - President and Chief Executive Officer Chris Scott - Chief Financial Officer Conference Call Participants Lisa Springer - Singular Research Presentation Operator Welcome to IRadimed Corporation's Second Quarter 2020 Financial Results Conference...

SA Transcripts on Seeking Alpha | August 1, 2020

IRADIMED CORPORATION Announces Second Quarter 2020 Financial Results

* Reports second quarter 2020 revenue of $6.8 million, GAAP diluted EPS of $(0.17) and non-GAAP diluted EPS of $0.05 * Reports combined cash and investments of $47.8 million as of June 30, 2020WINTER SPRINGS, Fla., July 30, 2020 (GLOBE NEWSWIRE) -- iRadimed Corporation (the “Company”) (NASDAQ: IRMD), a leader in the development of innovative magnetic resonance imaging (“MRI”) medical devices and the only known provider of a non-magnetic intravenous (“IV”) infusion pump system and non-magnetic patient vital signs monitoring system that are designed for use during MRI procedures, today announced financial results for the three and six months ended June 30, 2020.“As our customers continue being pressured in their efforts to respond to the current pandemic’s impacts, second quarter reven...

Yahoo | July 30, 2020

What Kind Of Shareholders Hold The Majority In IRadimed Corporation's (NASDAQ:IRMD) Shares?

If you want to know who really controls IRadimed Corporation (NASDAQ:IRMD), then you'll have to look at the makeup of...

Yahoo | July 27, 2020

Earnings Preview: iRadimed (IRMD) Q2 Earnings Expected to Decline

IRadimed (IRMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Yahoo | July 23, 2020

IRADIMED CORPORATION to Hold 2020 Second Quarter Financial Results Conference Call on July 30th

WINTER SPRINGS, Fla., July 16, 2020 -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2020 second quarter financial results before the.

Yahoo | July 16, 2020

Read More 'IRMD' Stories Here

IRMD Price Returns

1-mo 5.61%
3-mo 12.83%
6-mo 7.99%
1-year 8.83%
3-year 71.47%
5-year -22.54%
YTD 2.31%
2019 -4.42%
2018 61.45%
2017 36.49%
2016 -60.40%
2015 117.29%

Continue Researching IRMD

Want to see what other sources are saying about Iradimed Corp's financials and stock price? Try the links below:

Iradimed Corp (IRMD) Stock Price | Nasdaq
Iradimed Corp (IRMD) Stock Quote, History and News - Yahoo Finance
Iradimed Corp (IRMD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7193 seconds.